erythrodiol has been researched along with Osteosarcoma in 1 studies
*Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuong, NM; Fong, HH; Hoang, VD; Hung, NV; Pezzuto, JM; Soejarto, DD; Tan, GT; Zhang, HJ | 1 |
1 other study(ies) available for erythrodiol and Osteosarcoma
| Article | Year |
|---|---|
Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea.
Topics: Anti-HIV Agents; Chlorophyll; Ericales; Humans; Inhibitory Concentration 50; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Osteosarcoma; Plant Leaves; Plant Stems; Plants, Medicinal; Sesquiterpenes; Stereoisomerism; Triterpenes; Tumor Cells, Cultured; Vietnam | 2003 |